Satya Shreenivas
About Satya Shreenivas
Chief Medical Officer at HLT Medical
Satya Shreenivas has served as the Chief Medical Officer for HLT Medical, a transcatheter heart valve company. In this role, he has provided significant medical leadership and strategic direction for the company's clinical programs, particularly those focused on innovative solutions in structural heart disease.
Leadership at University of Cincinnati
Satya Shreenivas has led the structural heart program and the cardiac catheterization laboratory at the University of Cincinnati. His work in these roles contributed to advancements in structural heart treatments, providing top-tier care and pioneering new procedural techniques.
Service at The Christ Hospital and Medpace
Satya spent several years with The Christ Hospital in Ohio, where he contributed to the growth and success of the institution's cardiac care services. Additionally, he has served as Medical Director for Medpace, a clinical research organization, where he oversaw clinical trials and research initiatives.
Clinical Research and Publications
An investigator in many high-profile clinical trials, Satya Shreenivas has significantly impacted the field of cardiology. He has been widely published in peer-reviewed journals across the structural heart, heart failure, and coronary arenas, establishing a strong reputation for his research contributions.
Educational Background
Satya Shreenivas trained at the University of Pennsylvania and received an MBA from the Wharton School. His educational background combines advanced medical training with a strong understanding of business and healthcare management.
Role as Chief of Cardiology at Optum/SCA Health
Satya has served as Chief of Cardiology with Optum, a subsidiary of United Health, specifically with SCA Health. In this role, he has led cardiology services, contributing to the organization's strategic objectives in providing comprehensive cardiovascular care.
Advising on the EMPOWER Trial
Satya Shreenivas has been instrumental in advising Cardiac Dimensions on its EMPOWER Trial of the Carillon Mitral Contour System. His expertise in structural heart disease has been crucial in guiding the trial's progress and evaluating its outcomes.